XML 42 R30.htm IDEA: XBRL DOCUMENT
v3.23.3

Quarterly financial data - unaudited | 12 Months Ended
--- | ---
Dec. 31, 2022
Quarterly Financial Information Disclosure [Abstract] |
Quarterly financial data - unaudited | Quarterly financial data - unaudited The following tables set forth selected unaudited quarterly financial information for the years ended December 31, 2022 and 2021. The adjustments to the unaudited quarterly financial information below are the same as the Tax Adjustments and Other Adjustments made to the Company's audited consolidated financial statements as discussed in Note 2, "Restatement of consolidated financial statements".
|  | Three Months Ended |  | Three Months Ended
| March 31, 2022 |  | June 30, 2022
| Previously Reported |  | Tax Adjustments |  | Other Adjustments |  | As Revised |  | Previously Reported |  | Tax Adjustments |  | Other Adjustments |  | As Revised
Total revenues |  | $ | 307.5 |  |  | $ | — |  |  | $ | (2.7) |  |  | $ | 304.8 |  |  | $ | 242.7 |  |  | $ | — |  |  | $ | (0.1) |  |  | $ | 242.6 |
Cost of product sales |  | $ | 80.3 |  |  | $ | — |  |  | $ | (0.9) |  |  | $ | 79.4 |  |  | $ | 91.0 |  |  | $ | — |  |  | $ | 1.2 |  |  | $ | 92.2 |
Cost of CDMO |  | $ | 75.6 |  |  | $ | — |  |  | $ | (1.6) |  |  | $ | 74.0 |  |  | $ | 78.8 |  |  | $ | — |  |  | $ | 1.0 |  |  | $ | 79.8 |
Income (loss) from operations |  | $ | 6.4 |  |  | $ | — |  |  | $ | 0.5 |  |  | $ | 6.9 |  |  | $ | (72.0) |  |  | $ | — |  |  | $ | (4.3) |  |  | $ | (76.3) |
Net income (loss) |  | $ | (3.7) |  |  | $ | (1.4) |  |  | $ | 0.5 |  |  | $ | (4.6) |  |  | $ | (56.4) |  |  | $ | 7.8 |  |  | $ | (4.3) |  |  | $ | (52.9) |
Net income (loss) per common share: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Basic |  | $ | (0.07) |  |  | $ | (0.03) |  |  | $ | 0.01 |  |  | $ | (0.09) |  |  | $ | (1.13) |  |  | $ | 0.16 |  |  | $ | (0.09) |  |  | $ | (1.06) |
Diluted |  | $ | (0.07) |  |  | $ | (0.03) |  |  | $ | 0.01 |  |  | $ | (0.09) |  |  | $ | (1.13) |  |  | $ | 0.16 |  |  | $ | (0.09) |  |  | $ | (1.06) |
|  | Three Months Ended |  | Three Months Ended
|  | September 30, 2022 |  | December 31, 2022
|  | Previously Reported |  | Tax Adjustments |  | Other Adjustments |  | As Restated |  | Previously Reported |  | Tax Adjustments |  | Other Adjustments |  | As Restated
Total revenues |  | $ | 240.0 |  |  | $ | — |  |  | $ | (0.1) |  |  | $ | 239.9 |  |  | $ | 330.7 |  |  | $ | — |  |  | $ | (0.5) |  |  | $ | 330.2 |
Cost of product sales |  | $ | 85.5 |  |  | $ | — |  |  | $ | (0.3) |  |  | $ | 85.2 |  |  | $ | 167.3 |  |  | $ | — |  |  | $ | 0.5 |  |  | $ | 167.8 |
Cost of CDMO |  | $ | 63.1 |  |  | $ | — |  |  | $ | (1.1) |  |  | $ | 62.0 |  |  | $ | 52.1 |  |  | $ | — |  |  | $ | 0.6 |  |  | $ | 52.7 |
Income (loss) from operations |  | $ | (42.0) |  |  | $ | — |  |  | $ | (3.3) |  |  | $ | (45.3) |  |  | $ | (65.1) |  |  | $ | — |  |  | $ | 9.8 |  |  | $ | (55.3) |
Net income (loss) |  | $ | (75.7) |  |  | $ | (8.1) |  |  | $ | (3.3) |  |  | $ | (87.1) |  |  | $ | (88.0) |  |  | $ | 11.2 |  |  | $ | 9.8 |  |  | $ | (67.0) |
Net income (loss) per common share: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Basic |  | $ | (1.52) |  |  | $ | (0.16) |  |  | $ | (0.07) |  |  | $ | (1.75) |  |  | $ | (1.76) |  |  | $ | 0.22 |  |  | $ | 0.20 |  |  | $ | (1.34) |
Diluted |  | $ | (1.52) |  |  | $ | (0.16) |  |  | $ | (0.07) |  |  | $ | (1.75) |  |  | $ | (1.76) |  |  | $ | 0.22 |  |  | $ | 0.20 |  |  | $ | (1.34) |
|  | Three Months Ended |  | Three Months Ended
|  | March 31, 2021 |  | June 30, 2021
|  | Previously Reported |  |  |  | Other Adjustments |  | As Revised |  | Previously Reported |  |  |  | Other Adjustments |  | As Revised
Total revenues |  | $ | 343.0 |  |  |  |  | $ | 34.0 |  |  | $ | 377.0 |  |  | $ | 397.5 |  |  |  |  | $ | (20.1) |  |  | $ | 377.4 |
Cost of product sales |  | $ | 52.6 |  |  |  |  | $ | 0.2 |  |  | $ | 52.8 |  |  | $ | 81.2 |  |  |  |  | $ | 0.2 |  |  | $ | 81.4 |
Cost of CDMO |  | $ | 46.7 |  |  |  |  | $ | 37.7 |  |  | $ | 84.4 |  |  | $ | 146.6 |  |  |  |  | $ | (12.7) |  |  | $ | 133.9 |
Income (loss) from operations |  | $ | 95.4 |  |  |  |  | $ | (3.2) |  |  | $ | 92.2 |  |  | $ | 14.5 |  |  |  |  | $ | (7.4) |  |  | $ | 7.1 |
Net income (loss) |  | $ | 69.7 |  |  |  |  | $ | (2.4) |  |  | $ | 67.3 |  |  | $ | 4.6 |  |  |  |  | $ | (5.1) |  |  | $ | (0.5) |
Net income (loss) per common share: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Basic |  | $ | 1.31 |  |  |  |  | $ | (0.05) |  |  | $ | 1.26 |  |  | $ | 0.09 |  |  |  |  | $ | (0.10) |  |  | $ | (0.01) |
Diluted |  | $ | 1.28 |  |  |  |  | $ | (0.05) |  |  | $ | 1.23 |  |  | $ | 0.09 |  |  |  |  | $ | (0.10) |  |  | $ | (0.01) |
|  | Three Months Ended |  | Three Months Ended
| September 30, 2021 |  | December 31, 2021
| Previously Reported |  |  |  | Other Adjustments |  | As Revised |  | Previously Reported |  |  |  | Other Adjustments |  | As Revised
Total revenues |  | $ | 329.0 |  |  |  |  | $ | (42.7) |  |  | $ | 286.3 |  |  | $ | 723.2 |  |  |  |  | $ | 9.7 |  |  | $ | 732.9 |
Cost of product sales |  | $ | 103.2 |  |  |  |  | $ | 1.1 |  |  | $ | 104.3 |  |  | $ | 145.0 |  |  |  |  | $ | (0.9) |  |  | $ | 144.1 |
Cost of CDMO |  | $ | 114.3 |  |  |  |  | $ | (36.8) |  |  | $ | 77.5 |  |  | $ | 67.9 |  |  |  |  | $ | 1.8 |  |  | $ | 69.7 |
Income (loss) from operations |  | $ | (34.7) |  |  |  |  | $ | (10.0) |  |  | $ | (44.7) |  |  | $ | 277.4 |  |  |  |  | $ | 9.4 |  |  | $ | 286.8 |
Net income (loss) |  | $ | (32.7) |  |  |  |  | $ | (7.7) |  |  | $ | (40.4) |  |  | $ | 189.3 |  |  |  |  | $ | 3.8 |  |  | $ | 193.1 |
Net income (loss) per common share: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Basic |  | $ | (0.61) |  |  |  |  | $ | (0.14) |  |  | $ | (0.75) |  |  | $ | 3.55 |  |  |  |  | $ | 0.07 |  |  | $ | 3.62 |
Diluted |  | $ | (0.61) |  |  |  |  | $ | (0.14) |  |  | $ | (0.75) |  |  | $ | 3.53 |  |  |  |  | $ | 0.07 |  |  | $ | 3.60 |

X
- References No definition available. + Details
Name: | us-gaap_QuarterlyFinancialInformationDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -URI https://asc.fasb.org/topic&trid=2126967 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -SubTopic 10 -Section 50 -Paragraph 1B -URI https://asc.fasb.org/extlink&oid=126900988&loc=SL124452896-108306 + Details
Name: | us-gaap_QuarterlyFinancialInformationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration